This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.86% per year. These returns cover a period from January 1, 1988 through February 2, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
U.S. Inflation at a 40-Year High: 4 Sector ETFs to Win
by Sanghamitra Saha
The annual inflation rate in the United States accelerated to 7.5% in January of 2022, marking a new high since June of 1982.
Stocks & ETFs to Fall for in the Valentines' Week
by Sanghamitra Saha
The United States will be showered with love as 53% of its adults are planning to celebrate this Valentine's Day. Consumers are spending $175.41 on average this year, up about 6% from last year, per NRF data.
The Zacks Analyst Blog Highlights: XLF, EATZ and XLB
by Zacks Equity Research
XLF, EATZ and XLB are included in this analyst blog.
2021 U.S. GDP Growth Best Since 1984: Industry ETFs to Win
by Sanghamitra Saha
For full-year 2021, the economy advanced 5.7%, marking the highest since 1984.
3 Sector ETFs to Win Amid Rising Rates
by Sanghamitra Saha
The Fed is likely to hike rates in March with more hikes in the cards. These sectors are likely to benefit from rising rates.
ETFs & Stocks to Win Despite a Slump in December Retail Sales
by Sanghamitra Saha
U.S. retail sales declined 1.9% sequentially in December 2021, marking the biggest fall since February 2021.
U.S. Inflation Stands Tall: 4 Sector ETFs to Win
by Sanghamitra Saha
The annual inflation rate in the United States accelerated to 7% in December of 2021, marking a new 40-year high.
5 Sector ETFs That Crushed the Market in December
by Sweta Killa
With just a few trading sessions left to end December, the S&P 500 index has gained 4.8%. A few sector ETFs have outperformed.
ETFs & Stocks to Win Despite Slowing November Retail Sales
by Sanghamitra Saha
U.S. retail sales gained 0.3% sequentially in November 2021, following a 1.8% rise in October and well below market expectations of 08% as shoppers cut back on their discretionary spending due to the price inflation.
Travel ETFs Fly High as Omicron Fears Ease
by Sweta Killa
Bets that the new COVID-19 variant Omicron may cause milder illness than previously feared, renewed confidence in consumer and travel demand.